The letter follows up on the Senators’ February letter decrying ICE’s “excessive and seemingly indiscriminate” use of solitary confinement
WASHINGTON – U.S. Senate Majority Whip Dick Durbin (D-IL), Chair of the Senate Judiciary Committee, and Senators Patrick Leahy (D-VT), Dianne Feinstein (D-CA), Amy Klobuchar (D-MN), Mazie Hirono (D-HI), Cory Booker (D-NJ), and Alex Padilla (D-CA) today sent a second letter to Acting Director of U.S. Immigration and Customs Enforcement (ICE) Tae D. Johnson regarding ICE’s overuse of solitary confinement in detention facilities. Today’s letter follows Acting Director Johnson’s response to the Senators’ February letter that sought answers on ICE’s use of solitary confinement, its failure to conduct adequate oversight, and the consequences for the health and safety of detainees.
“[In February] We asked several questions related to a 2021 Department of Homeland Security Office of Inspector General (OIG) report that identified widespread deficiencies in ICE’s oversight of the use of solitary confinement in its detention facilities. Your response raises additional questions about ICE’s adherence to internal policies and apparent overuse of solitary confinement,” the Senators wrote.
Earlier this year, the Department of Homeland Security’s Office of Inspector General (OIG) released a report on ICE’s use of solitary confinement. The OIG investigation exposed serious deficiencies in ICE’s oversight and adherence to internal policies, and revealed information suggesting that facilities excessively rely on the dangerous detention practice, which involves placing detainees in isolated holding cells for as long as 22 to 24 hours a day with limited human contact.
In today’s letter, the Senators note that Acting Director Johnson’s response to their first letter failed to allay their concerns. They then continue to press Acting Director Johnson about the decision-making behind placing a detainee in solitary confinement and request additional information about ICE’s views on alternatives to solitary confinement.
“Your letter described how ICE uses a record-keeping system to track the usage of solitary confinement for a subset of detainees once they are placed in solitary confinement but does not explain what, if anything, ICE does to consider alternatives ahead of time. You also promised a policy update that will better ensure that ICE’s record-keeping system tracks all detainees placed in solitary confinement, but you have not explained how ICE plans to ensure that alternatives to solitary confinement are in fact considered or what those alternatives are,” the Senators wrote.
The Senators continued, “In response to our questions, your answers largely restate ICE’s pre-existing processes and reference the forthcoming policy update, which, to our knowledge, has still not been issued. Nor have you provided an adequate explanation of what steps ICE has taken or plans to take in order to address OIG’s findings.”
The Senators ended their letter by requesting answers to questions on alternatives to solitary confinement, the impact solitary confinement has on detainees’ health, and what standards will be instituted to prevent the continued overuse of solitary confinement.
Full text of today’s letter is available here and below:
August 1, 2022
Dear Acting Director Johnson:
We write regarding your March 21 response to our February 11 letter expressing concerns with the use of solitary confinement at U.S. Immigration and Customs Enforcement (ICE) facilities. We asked several questions related to a 2021 Department of Homeland Security Office of Inspector General (OIG) report that identified widespread deficiencies in ICE’s oversight of the use of solitary confinement in its detention facilities.[1] Your response raises additional questions about ICE’s adherence to internal policies and apparent overuse of solitary confinement.
One of the most troubling aspects of OIG’s report was its inability to confirm—for a majority of cases—whether ICE considered alternatives to solitary confinement, even though ICE’s own policies make clear that placing detainees in solitary confinement “requires careful consideration of alternatives” and “should occur only when necessary.”[2] Your letter described how ICE uses a record-keeping system to track the usage of solitary confinement for a subset of detainees once they are placed in solitary confinement but does not explain what, if anything, ICE does to consider alternatives ahead of time. You also promised a policy update that will better ensure that ICE’s record-keeping system tracks all detainees placed in solitary confinement, but you have not explained how ICE plans to ensure that alternatives to solitary confinement are in fact considered or what those alternatives are.
In response to our questions, your answers largely restate ICE’s pre-existing processes and reference the forthcoming policy update, which, to our knowledge, has still not been issued. Nor have you provided an adequate explanation of what steps ICE has taken or plans to take in order to address OIG’s findings. To address our continued concerns with ICE’s overuse of solitary confinement, please provide a staff-level briefing on this issue and written responses to each of the following questions by August 22, 2022:
2. If ICE ERO or the ICE Health Services Corp (IHSC) determine that segregation is not warranted or would be damaging to a detainee’s health, what are the available alternatives? Please provide a comprehensive list of alternatives to segregation that are currently available.
3. In addition to distributing translated handbooks on rules and regulations to detainees, what other steps has ICE taken to explore possible methods for limiting the use of segregation?
4.
Thank you for your prompt attention to this important request.
Sincerely,
-30-
[1] U.S. Dep’t of Homeland Security, Office of Inspector General, OIG-22-01, “ICE Needs to Improve Its Oversight of Segregation Use in Detention Facilities” (October 13, 2021), https://www.oig.dhs.gov/sites/default/files/assets/2021-10/OIG-22-01-Oct21.pdf.
[2] ICE Directive 11065.1 § 2.